PMV Pharmaceuticals

(NASDAQ) PMVP

Current Price$1.31

Market Cap$68.79M

Since IPO (2020)-97%

5 Year-96%

1 Year+51%

1 Month-4%

PMV Pharmaceuticals Financials at a Glance

Market Cap

$68.79M

Revenue (TTM)

$0.00

Net Income (TTM)

$78.34M

EPS (TTM)

$-1.48

P/E Ratio

-0.87

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Price

$1.31

Volume

553,552.017

Open

$1.29

Price

$1.31

Volume

553,552.017

Open

$1.29

Previous Close

$1.33

Daily Range

$1.23 - $1.38

52-Week Range

$0.81 - $1.88

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Price

$1.31

Volume

553,552.017

Open

$1.29

Previous Close

$1.33

Daily Range

$1.23 - $1.38

52-Week Range

$0.81 - $1.88

PMVP News

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps

Motley Fool Markets TeamAug 7, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PMV Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David H. Mack, PhD

Website

www.pmvpharma.com

Headquarters

Princeton, NJ 08512, US

PMVP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-63%

Return on Capital

-95%

Return on Assets

-81%

Earnings Yield

-1.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$68.79M

Shares Outstanding

53.33M

Volume

553.55K

Avg. Volume

679.09K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$86.21M

EBITDA

$86.07M

Operating Cash Flow

$73.58M

Capital Expenditure

$29.00K

Free Cash Flow

$73.61M

Cash & ST Invst.

$112.94M

Total Debt

$838.00K

PMV Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$68.79M

N/A

Market Cap/Employee

$1.46M

N/A

Employees

N/A

Net Income

$18.04M

-3.5%

EBITDA

$19.02M

+11.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$93.26M

-41.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$293.00K

-19.5%

Return on Assets

-81.13%

N/A

Return on Invested Capital

-95.11%

N/A

Free Cash Flow

$19.68M

-7.7%

Operating Cash Flow

$19.68M

-7.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TCRXTScan Therapeutics, Inc.

TCRXTScan Therapeutics, Inc.$1.11-4.31%

CBUSCibus, Inc.

CBUSCibus, Inc.$1.41-3.09%

ACRVAcrivon Therapeutics, Inc. Common Stock

ACRVAcrivon Therapeutics, Inc. Common Stock$1.92+0.00%

ATYRaTyr Pharma, Inc.

ATYRaTyr Pharma, Inc.$0.56+41.42%

BMEABiomea Fusion, Inc.

BMEABiomea Fusion, Inc.$1.43-3.38%

LITSLite Strategy, Inc.

LITSLite Strategy, Inc.$1.22+3.39%

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$11.21+0.27%

FFord Motor Company

FFord Motor Company$14.48+0.07%

AIIORobo.ai

AIIORobo.ai$5.64+1.16%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.65-0.01%

CSCOCisco Systems

CSCOCisco Systems$115.53+0.13%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.70-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$78.95+0.02%

Questions About PMVP

What is the current price of PMV Pharmaceuticals?

PMV Pharmaceuticals is trading at $1.33 per share.

What is the 52-week range for PMV Pharmaceuticals?

Over the past 52 weeks, PMV Pharmaceuticals has traded between $0.81 and $1.88.

How much debt does PMV Pharmaceuticals have?

As of the most recent reporting period, PMV Pharmaceuticals reported total debt of $293,000.

How much cash does PMV Pharmaceuticals have on hand?

PMV Pharmaceuticals reported $39.13M in cash and cash equivalents in its most recent financial results.

What is PMV Pharmaceuticals’s dividend yield?

PMV Pharmaceuticals does not currently have a dividend yield.

PMV Pharmaceuticals

PMV Pharmaceuticals Financials at a Glance

PMVP News

PMV Pharmaceuticals (PMVP) Q2 Loss Jumps

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About PMV Pharmaceuticals

PMVP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

PMV Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PMVP

What is the current price of PMV Pharmaceuticals?

What is the 52-week range for PMV Pharmaceuticals?

How much debt does PMV Pharmaceuticals have?

How much cash does PMV Pharmaceuticals have on hand?

What is PMV Pharmaceuticals’s dividend yield?

Premium Investing Services